HBW
NVO

Hazlett, Burt & Watson’s Novo Nordisk NVO Stock Holding History

Hazlett, Burt & Watson’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$361K Sell
9,821
-888
-8% -$42.1K 0.11% 177
2025
Q4 		$548K Sell
10,709
-1,583
-13% -$80.9K 0.18% 126
2025
Q3 		$684K Buy
12,292
+463
+4% +$27.1K 0.24% 98
2025
Q2 		$817K Buy
11,829
+1,516
+15% +$103K 0.33% 70
2025
Q1 		$714K Sell
10,313
-148
-1% -$12.2K 0.32% 74
2024
Q4 		$904K Buy
10,461
+741
+8% +$80.1K 0.4% 61
2024
Q3 		$1.16M Buy
9,720
+12
+0.1% +$1.6K 0.53% 43
2024
Q2 		$1.39M Buy
9,708
+408
+4% +$54.1K 0.72% 30
2024
Q1 		$1.2M Buy
9,300
+266
+3% +$31.7K 0.72% 25
2023
Q4 		$938K Buy
9,034
+3,494
+63% +$346K 0.63% 28
2023
Q3 		$503K Buy
5,540
+86
+2% +$7.58K 0.37% 52
2023
Q2 		$442K Buy
5,454
+16
+0.3% +$1.31K 0.33% 61
2023
Q1 		$434K Hold
5,438
– – 0.35% 57
2022
Q4 		$368K Hold
5,438
– – 0.32% 65
2022
Q3 		$270K Hold
5,438
– – 0.26% 81
2022
Q2 		$304K Sell
5,438
-350
-6% -$19.4K 0.28% 75
2022
Q1 		$320K Buy
+5,788
New +$297K 0.25% 84

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Hazlett, Burt & Watson's NVO Position: Q1 2026 in Review

Hazlett, Burt & Watson reduced its Novo Nordisk (NVO) stake by 8.3% in Q1 2026, selling an estimated $42.1K and leaving 9,821 shares worth $361K. The position accounts for 0.11% of the portfolio, ranked #177.

Hazlett, Burt & Watson first reported a position in NVO in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.39M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Hazlett, Burt & Watson held 9,821 shares of Novo Nordisk worth $361K as of Q1 2026.
  • Hazlett, Burt & Watson sold 888 Novo Nordisk shares in Q1 2026, an estimated $42.1K.
  • Novo Nordisk made up 0.11% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #177 holding.
  • Hazlett, Burt & Watson first reported a position in Novo Nordisk in Q1 2022 and has held it in 17 quarters since.
  • Hazlett, Burt & Watson's Novo Nordisk position peaked at $1.39M in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.